Peletidi, Aliki https://orcid.org/0000-0002-8703-497X
Kayyali, Reem
Article History
Received: 24 June 2022
Accepted: 2 November 2022
First Online: 18 November 2022
Declarations
:
: This study was ethically approved by the SEC Ethics Committee at Kingston University London (Ref: 1516/030), as well as by the Pharmaceutical Association of Achaia (Ref No. 56, 23/3/2016). Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests with respect to the research, authorship and/or publication of this article.